These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 8231166)
1. Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: its correlation with histopathology and prognosis. Yu DS; Hsu CM; Lee WH; Chang SY; Ma CP J Surg Res; 1993 Nov; 55(5):480-5. PubMed ID: 8231166 [TBL] [Abstract][Full Text] [Related]
2. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis. Larsson P Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395 [TBL] [Abstract][Full Text] [Related]
3. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma. Eskelinen M; Lipponen P; Nordling S Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637 [TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma. Tanioka F; Hiroi M; Yamane T; Hara H Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885 [TBL] [Abstract][Full Text] [Related]
5. [Flow cytometric analysis of renal cell carcinoma]. Lü GH Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):27-9. PubMed ID: 2364867 [TBL] [Abstract][Full Text] [Related]
6. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival. del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945 [TBL] [Abstract][Full Text] [Related]
7. Flow-cytometric analysis of the DNA content in paraffin-embedded tissue and in fresh tumour samples obtained from renal cell carcinoma: comparison of DNA ploidy using ethidium bromide and mithramycin. Fischer C; Knaust KO; Schauer A; Ringert RH Anticancer Res; 1996; 16(5A):2575-80. PubMed ID: 8917354 [TBL] [Abstract][Full Text] [Related]
8. In vivo aneuploidization during the expansion of renal adenocarcinoma. Di Capua Sacoto C; Budia Alba A; Alapont Alacreu JM; Ruiz Cerda JL; Jimenez Cruz JF Urol Int; 2011; 86(4):466-9. PubMed ID: 21546757 [TBL] [Abstract][Full Text] [Related]
9. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma. Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma. Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949 [TBL] [Abstract][Full Text] [Related]
13. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome. Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534 [TBL] [Abstract][Full Text] [Related]
14. Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis? Skolarikos A; Alivizatos G; Bamias A; Mitropoulos D; Ferakis N; Deliveliotis C; Dimopoulos MA Int J Urol; 2005 Jun; 12(6):563-9. PubMed ID: 15985079 [TBL] [Abstract][Full Text] [Related]
15. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis. Ljungberg B Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340 [TBL] [Abstract][Full Text] [Related]
16. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma. Yokogi H Cancer; 1996 Aug; 78(4):819-26. PubMed ID: 8756377 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era. Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666 [TBL] [Abstract][Full Text] [Related]
18. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate. Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index. Grignon DJ; Abdel-Malak M; Mertens W; Koster J; Keeney M; Sakr W; Shepherd RR Mod Pathol; 1995 Jan; 8(1):18-24. PubMed ID: 7731937 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma. Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]